These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

475 related items for PubMed ID: 33555529

  • 1. MicroRNA-424-5p enhances chemosensitivity of breast cancer cells to Taxol and regulates cell cycle, apoptosis, and proliferation.
    Dastmalchi N, Safaralizadeh R, Hosseinpourfeizi MA, Baradaran B, Khojasteh SMB.
    Mol Biol Rep; 2021 Feb; 48(2):1345-1357. PubMed ID: 33555529
    [Abstract] [Full Text] [Related]

  • 2. Tumor suppressive activity of miR-424-5p in breast cancer cells through targeting PD-L1 and modulating PTEN/PI3K/AKT/mTOR signaling pathway.
    Dastmalchi N, Hosseinpourfeizi MA, Khojasteh SMB, Baradaran B, Safaralizadeh R.
    Life Sci; 2020 Oct 15; 259():118239. PubMed ID: 32784058
    [Abstract] [Full Text] [Related]

  • 3. The combined therapy of miR-383-5p restoration and paclitaxel for treating MDA-MB-231 breast cancer.
    Dastmalchi N, Azarbarzin S, Safaralizadeh R, Khojasteh SMB, Shadbad MA, Amini M, Baghbanzadeh A, Asl ER, Baghbani E, Lotfinejad P, Baradaran B.
    Med Oncol; 2021 Nov 10; 39(1):9. PubMed ID: 34761351
    [Abstract] [Full Text] [Related]

  • 4. MiR-138-5p improves the chemosensitivity of MDA-MB-231 breast cancer cell line to paclitaxel.
    Rasoolnezhad M, Safaralizadeh R, Hosseinpour Feizi MA, Banan-Khojasteh SM, Roshani Asl E, Lotfinejad P, Baradaran B.
    Mol Biol Rep; 2023 Oct 10; 50(10):8407-8420. PubMed ID: 37620737
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA -383-5p restrains the proliferation and migration of breast cancer cells and promotes apoptosis via inhibition of PD-L1.
    Azarbarzin S, Hosseinpour-Feizi MA, Banan Khojasteh SM, Baradaran B, Safaralizadeh R.
    Life Sci; 2021 Feb 15; 267():118939. PubMed ID: 33359245
    [Abstract] [Full Text] [Related]

  • 6. Mechanism of miR-122-5p regulating the activation of PI3K-Akt-mTOR signaling pathway on the cell proliferation and apoptosis of osteosarcoma cells through targeting TP53 gene.
    Li KW, Wang SH, Wei X, Hou YZ, Li ZH.
    Eur Rev Med Pharmacol Sci; 2020 Dec 15; 24(24):12655-12666. PubMed ID: 33378012
    [Abstract] [Full Text] [Related]

  • 7. MiR-202-5p/PTEN mediates doxorubicin-resistance of breast cancer cells via PI3K/Akt signaling pathway.
    Liu T, Guo J, Zhang X.
    Cancer Biol Ther; 2019 Dec 15; 20(7):989-998. PubMed ID: 30983514
    [Abstract] [Full Text] [Related]

  • 8. PTENP1/miR-20a/PTEN axis contributes to breast cancer progression by regulating PTEN via PI3K/AKT pathway.
    Gao X, Qin T, Mao J, Zhang J, Fan S, Lu Y, Sun Z, Zhang Q, Song B, Li L.
    J Exp Clin Cancer Res; 2019 Jun 13; 38(1):256. PubMed ID: 31196157
    [Abstract] [Full Text] [Related]

  • 9. miR-215-5p is an anticancer gene in multiple myeloma by targeting RUNX1 and deactivating the PI3K/AKT/mTOR pathway.
    Liu S, Zhang Y, Huang C, Lin S.
    J Cell Biochem; 2020 Feb 13; 121(2):1475-1490. PubMed ID: 31498483
    [Abstract] [Full Text] [Related]

  • 10. miR-660-5p promotes breast cancer progression through down-regulating TET2 and activating PI3K/AKT/mTOR signaling.
    Peng B, Li C, He L, Tian M, Li X.
    Braz J Med Biol Res; 2020 Feb 13; 53(12):e9740. PubMed ID: 33146288
    [Abstract] [Full Text] [Related]

  • 11. MiR-155-5p exerts tumor-suppressing functions in Wilms tumor by targeting IGF2 via the PI3K signaling pathway.
    Luo X, Dong J, He X, Shen L, Long C, Liu F, Liu X, Lin T, He D, Wei G.
    Biomed Pharmacother; 2020 May 13; 125():109880. PubMed ID: 32004974
    [Abstract] [Full Text] [Related]

  • 12. MiRNA-138-5p: A strong tumor suppressor targeting PD-L-1 inhibits proliferation and motility of breast cancer cells and induces apoptosis.
    Rasoolnezhad M, Safaralizadeh R, Hosseinpourfeizi MA, Banan-Khojasteh SM, Baradaran B.
    Eur J Pharmacol; 2021 Apr 05; 896():173933. PubMed ID: 33545160
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA-130b targets PTEN to mediate drug resistance and proliferation of breast cancer cells via the PI3K/Akt signaling pathway.
    Miao Y, Zheng W, Li N, Su Z, Zhao L, Zhou H, Jia L.
    Sci Rep; 2017 Feb 06; 7():41942. PubMed ID: 28165066
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
    Fu X, Wen H, Jing L, Yang Y, Wang W, Liang X, Nan K, Yao Y, Tian T.
    Cancer Sci; 2017 Apr 06; 108(4):620-631. PubMed ID: 28132399
    [Abstract] [Full Text] [Related]

  • 15. miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27kip1 pathway.
    Wang DD, Yang SJ, Chen X, Shen HY, Luo LJ, Zhang XH, Zhong SL, Zhao JH, Tang JH.
    Tumour Biol; 2016 Nov 06; 37(11):15315-15324. PubMed ID: 27699665
    [Abstract] [Full Text] [Related]

  • 16. Thidiazuron suppresses breast cancer via targeting miR-132 and dysregulation of the PI3K-Akt signaling pathway mediated by the miR-202-5p-PTEN axis.
    Ibrahim HM, Ismail MB, Ammar RB, Ahmed EA.
    Biochem Cell Biol; 2021 Jun 06; 99(3):374-384. PubMed ID: 33103467
    [Abstract] [Full Text] [Related]

  • 17. MiR-135a-5p suppresses breast cancer cell proliferation, migration, and invasion by regulating BAG3.
    Zhang H, Wang M, Lang Z, Liu H, Liu J, Ma L.
    Clinics (Sao Paulo); 2022 Jun 06; 77():100115. PubMed ID: 36228497
    [Abstract] [Full Text] [Related]

  • 18. Circ-RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR-140-5p.
    Zang H, Li Y, Zhang X, Huang G.
    Thorac Cancer; 2020 Jul 06; 11(7):1891-1903. PubMed ID: 32445273
    [Abstract] [Full Text] [Related]

  • 19. miR-181 regulates cisplatin-resistant non-small cell lung cancer via downregulation of autophagy through the PTEN/PI3K/AKT pathway.
    Liu J, Xing Y, Rong L.
    Oncol Rep; 2018 Apr 06; 39(4):1631-1639. PubMed ID: 29484437
    [Abstract] [Full Text] [Related]

  • 20. MicroRNA-1297 contributes to tumor growth of human breast cancer by targeting PTEN/PI3K/AKT signaling.
    Liu C, Liu Z, Li X, Tang X, He J, Lu S.
    Oncol Rep; 2017 Oct 06; 38(4):2435-2443. PubMed ID: 28791363
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.